Tag
AstraZeneca
- Foresee Pharmaceuticals gains China approval for CAMCEVI 42 mg
- Arm CEO's AI cancer cure claims come amid pushback over similar ideas
- Emerging biomarkers may improve early colorectal cancer detection and treatment monitoring
- Novartis advances actinium-based cancer drug after promising trial data
- Ohio's 'Breath of Hope' Gala raises money for lung cancer research
- Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug
- Illumina partners with pharma giants to map disease biology at unprecedented scale
- Lung Cancer Research Foundation expands 2025 grant program
- Lung cancer awareness month: a Mugglehead roundup
- Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug
- This year's World Conference on Lung Cancer is coming to Barcelona
- Breath Diagnostics leader speaks at lung cancer education event in Louisville
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- International lung cancer screening market poised for steady growth: 2025 report
- AstraZeneca and AI startup join forces in the fight against lung cancer
- GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most
- AstraZeneca shares slide on disappointing lung cancer drug trial results
- AstraZeneca to expand US manufacturing for cell therapy
- AstraZeneca invests US$42M in Verge Genomics AI drug discovery platform